SCHEMBL4665083

SCHEMBL4665083

CCc1cccc(-c2cc(N)n(-c3cnccc3C)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 8/20 0.45
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
IDO1 P14902 2/20 0.40
KDM4E B2RXH2 2/20 0.40
STAT1 P42224 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666570 0.82 SMN1; SMN2 (0.48) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4668551 0.78 SMN1; SMN2 (0.46) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4665822 0.76 CA12 (0.46) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL4666522 0.75 KDM4C (0.43) MAPTALDH1A1KDM4ETP53LMNA
SCHEMBL4666864 0.74 SMN1; SMN2 (0.45) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4666599 0.74 ALDH1A1 (0.41) MAPTALDH1A1KDM4EKMT2ATP53
SCHEMBL14600210 0.73 DHODH (0.45) MAPTTP53
SCHEMBL12327191 0.71 CYP11B1 (0.47) IDO1CYP1A2NISCH
SCHEMBL4669491 0.70 SMN1; SMN2 (0.43) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL27836991 0.69 TLR7 (0.44) MAPTALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed